FOLH1 and neoplasm: Given the comparable liver-to-background ratios obtained for [68Ga]Ga-PSMA-11 and [18F]F-DCFPyL, it is reasonable to consider tumour uptake above the liver background level as a definition of PSMA-positivity prior to radioligand therapy when using [18F]F-DCFPyL.